1742 related articles for article (PubMed ID: 28642843)
1. The Impact of Genome Region of Difference 4 (RD4) on Mycobacterial Virulence and BCG Efficacy.
Ru H; Liu X; Lin C; Yang J; Chen F; Sun R; Zhang L; Liu J
Front Cell Infect Microbiol; 2017; 7():239. PubMed ID: 28642843
[TBL] [Abstract][Full Text] [Related]
2. Recombinant BCG Expressing ESX-1 of Mycobacterium marinum Combines Low Virulence with Cytosolic Immune Signaling and Improved TB Protection.
Gröschel MI; Sayes F; Shin SJ; Frigui W; Pawlik A; Orgeur M; Canetti R; Honoré N; Simeone R; van der Werf TS; Bitter W; Cho SN; Majlessi L; Brosch R
Cell Rep; 2017 Mar; 18(11):2752-2765. PubMed ID: 28297677
[TBL] [Abstract][Full Text] [Related]
3. Comparative genomics of BCG vaccines by whole-genome DNA microarray.
Behr MA; Wilson MA; Gill WP; Salamon H; Schoolnik GK; Rane S; Small PM
Science; 1999 May; 284(5419):1520-3. PubMed ID: 10348738
[TBL] [Abstract][Full Text] [Related]
4. Mycobacterium tuberculosis H37Rv: Delta RD1 is more virulent than M. bovis bacille Calmette-Guérin in long-term murine infection.
Sherman DR; Guinn KM; Hickey MJ; Mathur SK; Zakel KL; Smith S
J Infect Dis; 2004 Jul; 190(1):123-6. PubMed ID: 15195251
[TBL] [Abstract][Full Text] [Related]
5. A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection.
Yuan X; Teng X; Jing Y; Ma J; Tian M; Yu Q; Zhou L; Wang R; Wang W; Li L; Fan X
Appl Microbiol Biotechnol; 2015 Dec; 99(24):10587-95. PubMed ID: 26363555
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis.
Mahairas GG; Sabo PJ; Hickey MJ; Singh DC; Stover CK
J Bacteriol; 1996 Mar; 178(5):1274-82. PubMed ID: 8631702
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy and safety of vaccines against tuberculosis in the relation to genetic variability of Mycobacterium bovis BCG strains].
Prygiel M; Janaszek-Seydlitz W; Bucholc B
Przegl Epidemiol; 2011; 65(4):621-8. PubMed ID: 22390050
[TBL] [Abstract][Full Text] [Related]
8. Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti.
Pym AS; Brodin P; Brosch R; Huerre M; Cole ST
Mol Microbiol; 2002 Nov; 46(3):709-17. PubMed ID: 12410828
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein.
Deng YH; He HY; Zhang FJ
Scand J Immunol; 2013 Dec; 78(6):497-506. PubMed ID: 24283772
[TBL] [Abstract][Full Text] [Related]
10. Role of M. tuberculosis RD-1 region encoded secretory proteins in protective response and virulence.
Ganguly N; Siddiqui I; Sharma P
Tuberculosis (Edinb); 2008 Nov; 88(6):510-7. PubMed ID: 18640874
[TBL] [Abstract][Full Text] [Related]
11. The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue.
Hsu T; Hingley-Wilson SM; Chen B; Chen M; Dai AZ; Morin PM; Marks CB; Padiyar J; Goulding C; Gingery M; Eisenberg D; Russell RG; Derrick SC; Collins FM; Morris SL; King CH; Jacobs WR
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12420-5. PubMed ID: 14557547
[TBL] [Abstract][Full Text] [Related]
12. New clues to how the TB bacillus persists.
Wickelgren I
Science; 2000 May; 288(5470):1314-5. PubMed ID: 10847835
[No Abstract] [Full Text] [Related]
13. A mycobacterial virulence gene cluster extending RD1 is required for cytolysis, bacterial spreading and ESAT-6 secretion.
Gao LY; Guo S; McLaughlin B; Morisaki H; Engel JN; Brown EJ
Mol Microbiol; 2004 Sep; 53(6):1677-93. PubMed ID: 15341647
[TBL] [Abstract][Full Text] [Related]
14. Manipulation of BCG vaccine: a double-edged sword.
Singh VK; Srivastava R; Srivastava BS
Eur J Clin Microbiol Infect Dis; 2016 Apr; 35(4):535-43. PubMed ID: 26810060
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of protective efficacy conferred by a recombinant Mycobacterium bovis BCG expressing a fusion protein of Ag85A-ESAT-6.
Deng YH; He HY; Zhang BS
J Microbiol Immunol Infect; 2014 Feb; 47(1):48-56. PubMed ID: 23357605
[TBL] [Abstract][Full Text] [Related]
16. Genomics of Mycobacterium bovis.
Gordon SV; Eiglmeier K; Garnier T; Brosch R; Parkhill J; Barrell B; Cole ST; Hewinson RG
Tuberculosis (Edinb); 2001; 81(1-2):157-63. PubMed ID: 11463237
[TBL] [Abstract][Full Text] [Related]
17. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
18. Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens.
Brodin P; Majlessi L; Brosch R; Smith D; Bancroft G; Clark S; Williams A; Leclerc C; Cole ST
J Infect Dis; 2004 Jul; 190(1):115-22. PubMed ID: 15195250
[TBL] [Abstract][Full Text] [Related]
19. BCG Vaccines.
Tran V; Liu J; Behr MA
Microbiol Spectr; 2014 Feb; 2(1):MGM2-0028-2013. PubMed ID: 26082111
[TBL] [Abstract][Full Text] [Related]
20. Deletion of nuoG from the Vaccine Candidate Mycobacterium bovis BCG ΔureC::hly Improves Protection against Tuberculosis.
Gengenbacher M; Nieuwenhuizen N; Vogelzang A; Liu H; Kaiser P; Schuerer S; Lazar D; Wagner I; Mollenkopf HJ; Kaufmann SH
mBio; 2016 May; 7(3):. PubMed ID: 27222470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
